News | May 27, 2008

Epocrates Unveils New Oncology-Specific Mobile Software at ASCO 2008

May 28, 2008 – Clinicians attending this week’s American Society of Clinical Oncology (ASCO) 44th annual meeting in Chicago will learn about developments in cancer treatment, advances in technology and evidence-based practices in prevention and care.

In addition, all 30,000 attendees will have free access to a newly customized mobile suite from Epocrates Inc., that will reportedly help them continue to learn beyond the conference and stay current on the information needed to provide the best care for their patients.

The Epocrates Essentials for Oncology application combines relevant drug, disease and diagnostic information with many of the most commonly referenced medical tools. The mobile solution offers clinicians immediate access to content such as chemotherapy stages, cancer risk algorithms and treatment guidelines.

"Many of my patients are taking multiple therapies so it's imperative to check routinely for drug interactions and calculate accurate dosages,” said David Graham, M.D., medical director at Carle Clinic Association in Urbana, IL. "Epocrates also helps stimulate meaningful conversations with my patients about their cancer treatment and recovery, which makes them feel involved and more in control during this difficult time."

Since many oncologists divide time between the exam room and hospital, a mobile device with clinical software provides consistent accessibility to information clinicians need to support patient care. Nearly 60 percent of oncologists report avoiding one or more medical errors per week using Epocrates’ clinical software, said the company. Furthermore, more than half of oncologists report saving up to 20 minutes or more a day, allowing for more time with patients.

The Epocrates Essentials for Oncology mobile application features:

- Epocrates Essentials – The premium guide includes information on more than 3,300 drugs, including dosage for oncology-specific drugs and interactions with herbal remedies often used by cancer patients.

-Gail Breast Cancer Risk Calculator – This tool calculates a patient’s five-year risk of developing breast cancer based on inputs such as age and family history. This updated version of the breast cancer risk assessment tool, based on the industry-standard Gail algorithm, provides a more accurate prediction by leveraging the latest research from the National Cancer Institute.

- Oncology Calc – Combining some of the most commonly used calculators for oncology professionals, this suite includes calculators for an absolute neutrophil count, GFR for adults and children and opiate conversion. It also contains a Body Surface Area (BSA) and dosage calculator to determine proper medication dosages of cancer drugs and chemotherapy for individual patients, and a carboplatin AUC calculator that defines approximate cutoff levels of the chemotherapy medication.

- RCC Prognosis Calculator – Based on an advanced algorithm, this tool estimates the likely prognosis and survival rate for patients with various stages of renal cell carcinoma (RCC).

All ASCO meeting attendees can receive a complimentary one-year subscription to Epocrates Essentials for Oncology by visiting Epocrates’ booth at ASCO 2008 from May 30 – June 3.

For more information:

Related Content

FDA Approves Exablate Neuro for Tremor-Dominant Parkinson's Treatment
Technology | Focused Ultrasound Therapy | December 21, 2018
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
News | Radiation Dose Management | September 24, 2018
AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...